SFM
IPXL

Sphera Funds Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Sphera Funds Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,000
Closed -$689K – 157
2015
Q2 		$689K Sell
15,000
-85,000
-85% -$4.03M 0.07% 121
2015
Q1 		$4.69M Buy
+100,000
New +$3.98M 0.49% 47

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Sphera Funds Management's IPXL Position: Q3 2015 in Review

Sphera Funds Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2015, closing a stake of 15,000 shares — an estimated $689K sold.

Sphera Funds Management first reported a position in IPXL in Q1 2015 and held it in 2 quarters. The position peaked at $4.69M in Q1 2015. 195 funds tracked by Wall St. Rank hold IPXL as of Q3 2015.

  • Sphera Funds Management reported no remaining Impax Laboratories, Inc. position as of Q3 2015 after selling out during the quarter.
  • Sphera Funds Management sold 15,000 Impax Laboratories, Inc. shares in Q3 2015, an estimated $689K.
  • Sphera Funds Management first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 2 quarters.
  • Sphera Funds Management's Impax Laboratories, Inc. position peaked at $4.69M in Q1 2015.
  • 195 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2015.

Based on Sphera Funds Management's 13F filing for Q3 2015, filed 16 Nov 2015.